Compare Medtronic PLC (MDT) vs ABRDN Physical Gold Shares ETF (SGOL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs ABRDN Physical Gold Shares ETF — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while ABRDN Physical Gold Shares ETF trades at $39.92 (market cap $7.03B). The key difference: Medtronic PLC is far larger — about 16× ABRDN Physical Gold Shares ETF's market cap, and Medtronic PLC pays a 3.28% dividend while ABRDN Physical Gold Shares ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and ABRDN Physical Gold Shares ETF for 57 Days on average.
| MDT | SGOL | |
|---|---|---|
Market Cap | $112.24B | $7.03B |
Volume | 105,663,236 | 2,350,550 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $105.35 | $51.41 |
52-Week Low | $73.75 | $37.54 |
Typical Hold Time | 63 Days | 57 Days |
Enterprise Value | $131.58B | — |
Dividend Yield | 3.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong analyst support (60.8% buy ratings) and a $97.80 consensus price target suggesting 11.5% upside. The stock shows consistent earnings beats in recent quarters and maintains a 49-year dividend growth streak. However, technical indicators signal bearish momentum with resistance near $89-90. Revenue growth accelerated to $33.54B in 2025 with net margins improving to 13.93%, though debt levels have risen to 31.1% of assets.
MDT presents a compelling value opportunity with attractive dividend yield and earnings momentum, but faces near-term technical headwinds and increasing leverage. The upcoming Q3 earnings report and MiniMed separation will be critical catalysts. Investors should weigh the strong fundamental recovery against bearish technical signals and monitor debt management closely.
SGOL trades at $39.92, up 2.31% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The stock lacks key financial ratio data, making fundamental assessment difficult. Recent news highlights gold's sensitivity to Treasury yields and Fed policy, with prices under pressure from rising rates but finding some support from softer inflation data.
The outlook remains cautious due to bearish technicals and macroeconomic headwinds from interest rates. Investment opportunity hinges on gold's safe-haven appeal if economic uncertainty rises, but risks include persistent rate hikes and dollar strength dampening gold demand. Without current fundamentals, valuation is unclear.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About ABRDN Physical Gold Shares ETF
SGOL is an ETF that is designed to track the performance of the price of gold bullion. The fund is backed by physical gold held in secured vaults, which is allocated to the ETF's custodian account. By providing direct ownership of gold without the need for physical storage or insurance, SGOL offers investors a convenient and cost-effective way to gain exposure to the gold market.
Read more on SGOL →
